TY - JOUR
T1 - Can patients with asthma feel inhaler therapy working right away two clinical trials testing the effect of timing of assessment on patient perception
AU - Leidy, Nancy Kline
AU - Gutierrez, Benjamin
AU - Lampl, Kathy
AU - Uryniak, Tom
AU - O'Brien, Christopher D.
N1 - Funding Information:
The authors acknowledge Lisa Feder, Marissa Buttaro, and Sarita Shaevitz from Scientific Connexions (Newtown, PA, USA) for writing assistance funded by As-traZeneca LP. The authors thank the patients and all of the primary investigators and staff at the participating study sites (see http://www.clinicaltrials.gov, NCT00449527 and NCT00449501).
PY - 2009
Y1 - 2009
N2 - Background. Feeling a maintenance therapy work right away may provide positive reinforcement and may offer one way to improve adherence in patients with asthma. Precise measurement is required to accurately compare the presence of this effect across clinical trial treatment groups. Methods. Two randomized, controlled studies tested whether timing of assessment (daily vs weekly, study 1; and predose vs postdose, study 2) influenced patients' reports of whether they can feel a medication working right away (perception), and their satisfaction with this perception (satisfaction). These 2-week US-based multicenter double-blind, parallel-group studies included patients ≥18 years of age with mild to moderate persistent asthma. In each, patients were randomized to one of two drugs with different onset profiles: budesonide/formoterol pressurized metered-dose inhaler (pMDI) 80/4.5 μg × 2 inhalations (160/9 μg) twice daily or budesonide pMDI 80 μg × 2 inhalations (160 μg) twice daily. Patients were further randomized to complete previously validated perception and satisfaction questions in a cross-over fashion, either daily and weekly (N = 123) or predose and postdose (N = 134). Patient surveys also assessed perceptions of the onset of effect of medication and their value of these perceptions. Results. No significant differences were observed in patients' reports of perception, either daily versus weekly or predose versus postdose. A statistically significant difference in satisfaction was found in study 1 only, favoring weekly recall (p < 0.05), with sensitivity analysis showing no difference by treatment group (p = 0.162). Across both studies, most patients (87%) who perceived their inhaler working right away (136 of 157 patients) identified positive airway sensations. Most patients reported that feeling their medication work right away is reassuring and would help them manage their asthma. Conclusion. Assessment timing has no effect on patient response to the perception of feeling a medication working right away. Differences found in satisfaction levels reported with weekly versus daily recall were consistent across treatment groups, indicating that no bias was introduced in favor of either treatment group. Patients characterized the perception of feeling a maintenance therapy working right away as easier breathing and reported this perception as beneficial to patient self-care.
AB - Background. Feeling a maintenance therapy work right away may provide positive reinforcement and may offer one way to improve adherence in patients with asthma. Precise measurement is required to accurately compare the presence of this effect across clinical trial treatment groups. Methods. Two randomized, controlled studies tested whether timing of assessment (daily vs weekly, study 1; and predose vs postdose, study 2) influenced patients' reports of whether they can feel a medication working right away (perception), and their satisfaction with this perception (satisfaction). These 2-week US-based multicenter double-blind, parallel-group studies included patients ≥18 years of age with mild to moderate persistent asthma. In each, patients were randomized to one of two drugs with different onset profiles: budesonide/formoterol pressurized metered-dose inhaler (pMDI) 80/4.5 μg × 2 inhalations (160/9 μg) twice daily or budesonide pMDI 80 μg × 2 inhalations (160 μg) twice daily. Patients were further randomized to complete previously validated perception and satisfaction questions in a cross-over fashion, either daily and weekly (N = 123) or predose and postdose (N = 134). Patient surveys also assessed perceptions of the onset of effect of medication and their value of these perceptions. Results. No significant differences were observed in patients' reports of perception, either daily versus weekly or predose versus postdose. A statistically significant difference in satisfaction was found in study 1 only, favoring weekly recall (p < 0.05), with sensitivity analysis showing no difference by treatment group (p = 0.162). Across both studies, most patients (87%) who perceived their inhaler working right away (136 of 157 patients) identified positive airway sensations. Most patients reported that feeling their medication work right away is reassuring and would help them manage their asthma. Conclusion. Assessment timing has no effect on patient response to the perception of feeling a medication working right away. Differences found in satisfaction levels reported with weekly versus daily recall were consistent across treatment groups, indicating that no bias was introduced in favor of either treatment group. Patients characterized the perception of feeling a maintenance therapy working right away as easier breathing and reported this perception as beneficial to patient self-care.
KW - Asthma
KW - Bronchodilation
KW - Budesonide/formoterol
KW - Onset of effect
KW - Patient satisfaction
KW - Patient-reported outcome
KW - Recall
UR - http://www.scopus.com/inward/record.url?scp=72049101883&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=72049101883&partnerID=8YFLogxK
U2 - 10.3109/02770900903301260
DO - 10.3109/02770900903301260
M3 - Article
C2 - 19995138
AN - SCOPUS:72049101883
SN - 0277-0903
VL - 46
SP - 1006
EP - 1012
JO - Journal of Asthma
JF - Journal of Asthma
IS - 10
ER -